Kelly Scott A. 4
4 · CytoDyn Inc. · Filed Nov 30, 2022
Insider Transaction Report
Form 4
CytoDyn Inc.CYDY
Kelly Scott A.
Director
Transactions
- Award
Non-qualified stock option (right to buy)
2022-11-28+2,315,439→ 2,315,439 totalExercise: $0.35Exp: 2032-11-28→ Common Stock (2,315,439 underlying) - Award
Common Stock
2022-11-30+16,927→ 2,184,037 total
Holdings
- 782,408(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary.
- [F2]241,190 shares vested on November 28, 2022; the balance will vest on a monthly basis as follows (i) 48,238 shares at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended), from November 2022 through February 2025, and (ii) 48,239 shares at the conclusion of each month of Continuous Service, from March 2025 through May 2026.